Section Editor: Brian G. DeRubertis, MD, FACS, Chief of the Division of Vascular and Endovascular Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical School, New York, NY
At the 2024 SIR Meeting in Salt Lake City, Utah, interventional radiologist Mark Lessne, MD presented several sessions, including “Beyond Paclitaxel." VDM spoke with Dr. Lessne about his presentation and the future of PAD management.
At the 2024 SIR Meeting in Salt Lake City, Utah, interventional radiologist Mark Lessne, MD presented several sessions, including “Beyond Paclitaxel." VDM spoke with Dr. Lessne about his presentation and the future of PAD management.
At the 2024 SIR Meeting, Waseem Wahood, MD, MS presented results from a study that analyzed 30-day perioperative outcomes from the National Surgical Quality Improvement Project in patients who received intervention for CLTI.
At the 2024 SIR Meeting, Waseem Wahood, MD, MS presented results from a study that analyzed 30-day perioperative outcomes from the National Surgical Quality Improvement Project in patients who received intervention for CLTI.
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan
Tatsuya Nakama, MD
Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany
Ralf Langhoff
Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Tim Wittig, MD
University Hospital Leipzig, Germany
Tim Wittig, MD
University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
Yolanda Bryce, MD, RPVI
Memorial Sloan Kettering Cancer Center, New York, New York
Yolanda Bryce, MD, RPVI
Memorial Sloa...
At the 2024 SIR Meeting, Dr. Yolanda Bryce, MD, RPVI, presented a session on “Crossing Techniques and Reentry Procedures for Complex Chronic Iliac Occlusions.” VDM spoke with Dr. Bryce about her presentation.
At the 2024 SIR Meeting, Dr. Yolanda Bryce, MD, RPVI, presented a session on “Crossing Techniques and Reentry Procedures for Complex Chronic Iliac Occlusions.” VDM spoke with Dr. Bryce about her presentation.
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Cardiovascular Institute of the South Press Release
Cardiovascular Institute of the South...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Alik Farber, MD
Boston Medical Center, Boston, Massachusetts
Alik Farber, MD
Boston Medical Center...
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Michael Lichtenberg, MD, FESC
Vascular Centre Clinic, Arnsberg, Germany
Michael Lichtenberg, MD, FESC
Vascula...
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Gary Ansel, MD; Sean Lyden, MD; Lucas Ferrer Cardona, MD; Dean Ferrera, DO
Gary Ansel, MD; Sean Lyden, MD; Lucas...
Gary Ansel, MD, Sean Lyden, MD, Lucas Ferrer Cardona, MD and Dean Ferrera, DO describe the impact of the Pounce™ Thrombectomy System on the removal of peripheral arterial thrombi and emboli.
Gary Ansel, MD, Sean Lyden, MD, Lucas Ferrer Cardona, MD and Dean Ferrera, DO describe the impact of the Pounce™ Thrombectomy System on the removal of peripheral arterial thrombi and emboli.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.
Purpose: Below-knee amputation (BKA), either at the time of creation or after use, in patients with severe peripheral arterial disease (PAD) is complicated, with tissue necrosis leading t...
Purpose: In the United States, it is estimated that 6.5 million people over the age of 40 have peripheral arterial disease (PAD). Radiologists examine computed tomography angiography (CTA...
Purpose: Gold standard treatment for occlusive lesions of the common femoral artery (CFA) used to be endarterectomy. In recent years, interest for endovascular treatment of the CFA has be...
Purpose: Chronic limb-threatening ischemia has associated morbidity, mortality, and impact on quality of life. This endovascular case had a high-complexity target path anatomy with retrog...
Purpose: We report the 24-month outcomes of the PROMISE I early US feasibility study (EFS) after treatment of no-option chronic limb-threatening ischemia (CLTI) with Transcatheter Arteria...
Purpose: The purpose of this study was analysis of clinical characteristics and results of surgical revascularization in patients with acute limb ischemia (ALI) and COVID-19, compared wit...
Purpose: Acute limb ischemia (ALI) occurs with an abrupt interruption of blood flow to the extremity and a sudden decrease in limb perfusion, threatening the limb viability. The incidenc...
Kailin Opella, Andrew Ibrahim, Vivie Tran, Annmarie Farag, Minnie Tran, Mohammad Ansari
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, Texas
Introducti...
Subash Swarna, Seena Firouzbakht, Vivie Tran, Amber Hernandez, Hoang Ho, Leigh A. Jenkins, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Cen...
Vivie Tran, Alistair Disraeli, Nate Fernandez, Karter Morris, Hoang Ho, Dixon Santana, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, ...
Vivie Tran, Hoang Ho, Steven Daley, Simon Williams, MD, Aliakbar Arvandi, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, ...
Vivie Tran, Hoang Ho, Subash Swarna, Andrew Ibrahim, Minnie Tran, Steven Daley, Simon Williams, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences...
Sachi Khemka, Hannah Seo, Vivie Tran, Kailin Opella, Esther Burns, Hoang Ho, Marina Iskandir, MD, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences C...
Vivie Tran, Daniel Xue, Sachi Khemka, Hoang Ho, Mohammad M. Ansari, MD
PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Andrew Ibrahim, Mohamad Altabaa, Zeba Momin, Maryam Niazi, Anthony Bruccoliere, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD
PAD Center of Excellence, Texas Tec...
Andrew Ibrahim, Caroline Cushman, Mitchell DeVolder, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD
PAD Center of Excellence, Texas Tech University Health Science...
A. Powell, T. Maldonado, K. Nagarsheth, J. Rowse, J. Chung
A. Powell, T. Maldonado, K. Nagarshet...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan
Tatsuya Nakama, MD
Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany
Ralf Langhoff
Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Tim Wittig, MD
University Hospital Leipzig, Germany
Tim Wittig, MD
University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
Chief Scientific & Medical Officer, American Diabetes Association, Arlington, Virginia
Presented by Robert A. Gabbay, MD, Ph...
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Department of Surgery, University Medical Centre, Groningen, The Netherlands
Jean-Paul de Vries
Department of Sur...
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Columbia University Irving Medical Center, New York, New York
Sahil Parikh, MD
Columbia University...
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
University Heart and Vascular Center of the University Hospital, Hamburg-Eppendorf, Germany
Erwin Blessing, MD
University Heart ...
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
Robert Lookstein, MD
Icahn School of Medicine at Mount Sinai, New York, New York
Robert Lookstein, MD
Icahn School of ...
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany
Nikolaos Tsilimparis, MD
University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan
Tatsuya Nakama, MD
Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany
Ralf Langhoff
Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Tim Wittig, MD
University Hospital Leipzig, Germany
Tim Wittig, MD
University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
Oliver Schlager, MD
Medical University of Vienna, Austria
Oliver Schlager, MD
Medical Universit...
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Peter A. Schneider, MD
University of California, San Francisco
Peter A. Schneider, MD
University of ...
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
Lorenzo Patrone, MD
West London Vascular and Interventional Centre, London, UK
Lorenzo Patrone, MD
West London Vascu...
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
Manuela Konert, MD
University Hospital Leipzig, Germany
Manuela Konert, MD
University Hospita...
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany.
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany.
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Houma, LA – Terrebonne General Health System (Terrebonne General) and Cardiovascular Institute of the South (CIS) are the first in the Gulf South and only one of five in the country to use the new FDA-approved Esprit™ BTK (Below the Knee)...
Houma, LA – Terrebonne General Health System (Terrebonne General) and Cardiovascular Institute of the South (CIS) are the first in the Gulf South and only one of five in the country to use the new FDA-approved Esprit™ BTK (Below the Knee)...
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Cardiovascular Institute of the South Press Release
Cardiovascular Institute of the South...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
Novel bioresorbable scaffold system being developed for expanded indications
LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ -- Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that the United...
Novel bioresorbable scaffold system being developed for expanded indications
LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ -- Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that the United...
Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee,...
Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee,...
ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.